These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20724317)

  • 1. Bacterial conjunctivitis in children: antibacterial treatment options in an era of increasing drug resistance.
    Pichichero ME
    Clin Pediatr (Phila); 2011 Jan; 50(1):7-13. PubMed ID: 20724317
    [No Abstract]   [Full Text] [Related]  

  • 2. A multicenter comparison of polymyxin B sulfate/trimethoprim ophthalmic solution and moxifloxacin in the speed of clinical efficacy for the treatment of bacterial conjunctivitis.
    Granet DB; Dorfman M; Stroman D; Cockrum P
    J Pediatr Ophthalmol Strabismus; 2008; 45(6):340-9. PubMed ID: 19043945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of current antibiotics for the treatment of bacterial conjunctivitis.
    Karpecki P; Paterno MR; Comstock TL
    Optom Vis Sci; 2010 Nov; 87(11):908-19. PubMed ID: 20838353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children.
    Isenberg SJ; Apt L; Valenton M; Del Signore M; Cubillan L; Labrador MA; Chan P; Berman NG
    Am J Ophthalmol; 2002 Nov; 134(5):681-8. PubMed ID: 12429243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Besifloxacin ophthalmic suspension for bacterial conjunctivitis.
    Nafziger AN; Bertino JS
    Drugs Today (Barc); 2009 Aug; 45(8):577-88. PubMed ID: 19927224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxifloxacin versus polymyxin B/trimethoprim sulfate in pediatric bacterial conjunctivitis.
    Wagner RS
    J Pediatr Ophthalmol Strabismus; 2008; 45(6):330. PubMed ID: 19043943
    [No Abstract]   [Full Text] [Related]  

  • 7. Besifloxacin, a new ophthalmic fluoroquinolone for the treatment of bacterial conjunctivitis.
    Bertino JS; Zhang JZ
    Expert Opin Pharmacother; 2009 Oct; 10(15):2545-54. PubMed ID: 19743941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary meningococcal conjunctivitis.
    Orden B; Martínez R; Millán R; Belloso M; Pérez N
    Clin Microbiol Infect; 2003 Dec; 9(12):1245-7. PubMed ID: 14686993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single-blinded randomized clinical trial comparing polymyxin B-trimethoprim and moxifloxacin for treatment of acute conjunctivitis in children.
    Williams L; Malhotra Y; Murante B; Laverty S; Cook S; Topa D; Hardy D; Wang H; Gigliotti F
    J Pediatr; 2013 Apr; 162(4):857-61. PubMed ID: 23092529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiological etiology and susceptibility of bacterial conjunctivitis isolates from clinical trials with ophthalmic, twice-daily besifloxacin.
    Haas W; Gearinger LS; Hesje CK; Sanfilippo CM; Morris TW
    Adv Ther; 2012 May; 29(5):442-55. PubMed ID: 22644963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials.
    Comstock TL; Paterno MR; Usner DW; Pichichero ME
    Paediatr Drugs; 2010 Apr; 12(2):105-12. PubMed ID: 20218747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlling contagious bacterial conjunctivitis.
    Lichtenstein SJ; Dorfman M; Kennedy R; Stroman D
    J Pediatr Ophthalmol Strabismus; 2006; 43(1):19-26. PubMed ID: 16491721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a survey of children with acute bacterial conjunctivitis treated with trimethoprim-polymyxin B ophthalmic solution.
    Wagner RS
    Clin Ther; 1995; 17(5):875-81. PubMed ID: 8595639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Besifloxacin Ophthalmic Suspension 0.6% Compared with Gatifloxacin Ophthalmic Solution 0.3% for the Treatment of Bacterial Conjunctivitis in Neonates.
    Sanfilippo CM; Allaire CM; DeCory HH
    Drugs R D; 2017 Mar; 17(1):167-175. PubMed ID: 28078599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylaxis to polymyxin B-trimethoprim eye drops.
    Henao MP; Ghaffari G
    Ann Allergy Asthma Immunol; 2016 Apr; 116(4):372. PubMed ID: 26922212
    [No Abstract]   [Full Text] [Related]  

  • 16. [How to prescribe topical antibiotics in ophthalmology].
    Robert PY
    J Fr Ophtalmol; 2007 Apr; 30(4):417-22. PubMed ID: 17486039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Besifloxacin: a topical fluoroquinolone for the treatment of bacterial conjunctivitis.
    Chang MH; Fung HB
    Clin Ther; 2010 Mar; 32(3):454-71. PubMed ID: 20399984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.
    McDonald MB; Protzko EE; Brunner LS; Morris TW; Haas W; Paterno MR; Comstock TL; Usner DW
    Ophthalmology; 2009 Sep; 116(9):1615-1623.e1. PubMed ID: 19643483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chlamydial conjunctivitis.
    Nakagawa H
    Ophthalmologica; 1997; 211 Suppl 1():25-8. PubMed ID: 9065934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New antibacterial drugs for topical ophthalmic use.
    Yolton DP
    Optom Clin; 1992; 2(4):59-72. PubMed ID: 1286241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.